Enbiosis
PrivateLast Round
VC Round
Jan 22, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Enbiosis operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a VC Round in January 2024.
Enbiosis is a biotechnology company that provides AI-powered gut health solutions for personalized care and precision nutrition.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine, Vertical SaaS
Business Model
B2B
Customer Profile
Usage-Based SaaS, Data as a Service, Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enbiosis Comparables
Compare Enbiosis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biohm Technologies | 78% | |
| Biomesight | 77% | |
| Microba Life Sciences Ltd | 76% |
For institutional investors. Book with your work email.
Enbiosis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 22, 2024 | ||||
| Accelerator | May 1, 2023 | ||||
| Seed | May 27, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Enbiosis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QINVEST Portföy Yönetimi A.Ş. | VC Round |
| London & Partners | Accelerator |
| Pragma Capital Partners | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 72% MoM.
- Jun 18, 2026
Monthly visitors increased 138% MoM, reaching 3.9K.
For institutional investors. Book with your work email.
Enbiosis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Enbiosis's valuation, stock price, and market status.
Is Enbiosis a public or private company?
Enbiosis is a private company.
What is the current stock price of Enbiosis?
Enbiosis is a private company, so its shares have no public market price. Caplight tracks Enbiosis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enbiosis worth (valuation)?
Valuation information for Enbiosis is not publicly available.
Can I buy Enbiosis stock?
Enbiosis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enbiosis's last funding round?
Enbiosis's most recent funding round was VC Round on January 22, 2024.
Who are the main investors in Enbiosis?
Key investors in Enbiosis include QINVEST Portföy Yönetimi A.Ş., London & Partners, Pragma Capital Partners.
Will Enbiosis IPO soon?
No public IPO plans have been announced for Enbiosis.
How can I track Enbiosis secondary market activity?
Caplight tracks bids, offers, and trades in Enbiosis's shares on secondary markets.